2008: Antiphospholipid Syndrome
Search or Browse by Day

Antiphospholipid Syndrome

Sunday, October 26, 2008
1
High Titer ( > 80U) Anti-Beta2-Glycoprotein-I Antibody (aβ2GPI) Positivity in Persistently High Titer ( > 80U) Anticardiolipin Antibody (aCL) Positive Patients: Does it Offer Additional Information?
2
The Correlation Between Anticardiolipin and Anti-β2-Glycoprotein-I (aβ2GPI) Antibody Titers
3
Clinical significance of IgA Anti-β 2 glycoprotein 1 Antibodies in Patients with Systemic Lupus Erythematosus
4
Clinical Differences In Late Vs. Early-onset Primary Antiphospholipid Syndrome
5
Monocentric Study of 28 Patients with Chorea in the Setting of Systemic Lupus Erythematosus and/or Antiphospholipid Antibodies
6
Middle Aortic Syndrome in the Antiphospholipid (Hughes) Syndrome
7
Arterial stiffness, Endothelial Dysfunction, Cardiovascular Risk Factors in Patients with Antiphospholipid Syndrome and Renal Artery Stenosis
8
Contrasting Roles of Complement C4 and C3 in Human Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE)
9
Inhibition Of Complement Activation By Heparin And Low Molecular Weight Heparins: Discordant Effects On Alternative, Mannose Binding Lectin (MBL), And Classical Pathways
10
Effects Of Fluvastatin On Prothrombotic/proinflammatory Markers In Patients With Antiphospholipid Syndrome
11
A Novel Therapeutic Strategy For The Antiphospholipid Syndrome (APS) Via The Creation Of Decoy And Mutant ‘Super-Decoy’ Peptides
12
Endogenous Thrombin Potential (ETP) in the Assessment of Hypercoagulability in SLE
13
Protein C Pathway Abnormalities are Risk Factors for Thrombosis and Pregnancy Loss in Patients with Antiphospholipid Antibodies
14
Beta 2 Glycoprotein I (B2GPI) Binds Platelet Factor 4 (PF4): Implications for the Pathogenesis of Antiphospholipid Syndrome
15
Antiphospholipid-antibodies (apl) Induce Toll-like Receptor 7 Expression In Mouse Models
16
Cultured Endothelial Cells Produce Microparticles when Stimulated with Human Polyclonal and Monoclonal IgG Antiphospholipid Antibodies
17
Antiphospholipid Antibodies Induce Procoagulant Activity In Human Plasmacytoid Dendritic Cells Via Toll-like Receptor 7
18
In Vivo Involvement Of Apolipoprotein E Receptor on Thrombogenic Effects Of A Dimeric β2glycoprotein I and of Antiphospholipid Antibodies
19
CNS Impairment Induced by Antiphospholipid Antibodies Via Specific Binding to the Mouse Brain
20
Induction Of Pathogenic Antiphospholipid Antibodies In Vivo Are Dependent On Expression Of MHC-II Genes
21
STAT4 Polymorphisms are Associated with Not Only Systemic Lupus Erythematosus But Also Antiphospholipid Syndrome
640
Absence of Lupus Anticoagulant is a Strong Predictor of Uncomplicated Pregnancy in Patients with APL Antibodies
641
Novel Autoantibodies Against the Coagulation Factor FIXa in the Antiphospholipid Syndrome that Interfere with the FIXa regulation by Antithrombin
642
Sequence Motifs in a Human Monoclonal Antiphospholipid Antibody Determine its Ability to Bind and Affect the Function of Serine Proteases
643
Pathogenic Effects Of Antiphospholipid Antibodies Are Ameliorated In Annexin A2 Deficient Mice
644
Pregnant Naïve Mice Are Protected From APL-Induced Fetal Loss By The Injection Of A Synthetic Peptide (TIFI) Mimicking The B2GPI PL-binding Site
645
The Phosphatidylserine-dependent Monoclonal Antiprothrombin Antibody With Lupus Anticoagulant Activity Induces Tissue Factor And Adhesion Molecules Expression On Endothelial Cells:possible Implication Of P38 Mitogen-activate Protein Kinase (MAPK) Pathway
See more of: ACR Abstract Submission Poster Sessions
<< Previous Session Level | Next Session Level >>